Forum for Science, Industry and Business
Sponsored by:     Siemens  n-tv 
Search our Site:

Topic (optional):

 

Home Reports Studies and Analyses Content

New Study Suggests that High-Dose Hormone Treatment Might Reduce Risk for PTSD

next article
22.10.2008

Cortisol helps our bodies cope with stress, but what about its effects on the brain?

 

A new study by Cohen and colleagues, appearing in the October 15th issue of Biological Psychiatry, suggests that the answer to this question is complex.


In an animal model of posttraumatic stress disorder (PTSD), high doses of a cortisol-related substance, corticosterone, prevented negative consequences of stress exposure, including increased startle response and behavioral freezing when exposed to reminders of the stress.

However, low-dose corticosterone potentiated these responses. This finding suggests that corticosterone levels may influence both vulnerability and resilience in a dose-dependent manner through its involvement in memory processes.

One of the complexities in understanding PTSD is the context-dependency of adaptation. In some situations, for example following a car accident in an otherwise secure community, one objective of treatment is to restore a sense of normalcy and control of one’s life. Within this context, the high-dose corticosterone would seem to be the indicated treatment. However, one could imagine scenarios where hypervigilance and heightened emotional reactivity could be adaptive, perhaps in a combat zone.

In that case, the lower and more typical corticosterone levels might help soldiers adapt to the continuing risks of combat. But, people do not spend their lives in a single context. “In the case of helping soldiers adjust to the stress of war, we have to think both short-term and long-term, to help soldiers adjust to combat, but also to help them return from combat to resume peacetime life. Thus, we need further guidance from animal research about how to help soldiers adjust flexibly across contexts, from the battlefield to the breakfast table,” as explained by John H. Krystal, M.D., Editor of Biological Psychiatry and affiliated with both Yale University School of Medicine and the VA Connecticut Healthcare System.

Corresponding author Dr. Hagit Cohen concludes that, “single high-dose corticosteroid treatment may thus be worthy of clinical investigation as a possible avenue for early pharmacotherapeutic intervention in the acute phase, aimed at prevention of chronic stress-related disorders, such as PTSD. In this sense, it brings treatment of PTSD to a new era – an era of secondary prevention.”

Jayne Dawkins | Source: alphagalileo
Further information: www.elsevier.com

next article

More articles from Studies and Analyses:

nachricht Airborne nitrogen shifts aquatic nutrient limitation in pristine lakes
06.11.2009 | Arizona State University

nachricht Why Nice Guys Usually Get the Girls
06.11.2009 | University of Arizona

All articles from Studies and Analyses >>>

B2B Search

Product / Service
Company / Organisation

Latest News

Airborne nitrogen shifts aquatic nutrient limitation in pristine lakes

06.11.2009 | Studies and Analyses

Genome sequence for the domestic horse to be unveiled

06.11.2009 | Life Sciences

New Study in Geology Uses Satellite Imagery to Identify Active Magma Systems in East Africa’s Rift Valley

06.11.2009 | Earth Sciences

VideoLinks

Event News

Texas Tech University Hosts Major Textile Conference in India

06.11.2009 | Event News

Brief Highlights of the Fluid Dynamics Conference, Minneapolis

30.10.2009 | Event News

EUROSAFE Forum 2009 Brussels: "Safety Implications of an Increased Demand for Nuclear Energy"

29.10.2009 | Event News